RIGL RIGEL PHARMACEUTICALS
Health Care · Russell 2000
Next earnings: not announced yet
What 7 analyst firms say about RIGEL PHARMACEUTICALS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
6 rated views · 7 analyst/firm records · 7 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8022
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8016
Recent analyst activity · last 90 days
Our tracked history has 5 reports on RIGL from 4 analyst firms in the last 90 days (7 firms in the past year).
Comparing each firm's latest target with its previous one: 1 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Cantor Fitzgerald | Kristen Kluska | Hold | 22 Jun 2026 | 43.00 USD |
| Citigroup | Yigal Nochomovitz | Buy | 6 Aug 2026 | 83.00 USD |
| H.C. Wainwright | Joseph Pantginis | Buy | 19 Oct 2026 | 85.00 USD |
| Jefferies | Farzin Haque | Buy | 1 Jul 2026 | 55.00 USD |
| Piper Sandler | Allison Bratzel | Hold | 17 Aug 2026 | 49.00 USD |
| Weiss Ratings | Unnamed analyst | — | 8 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Sell | 14 Oct 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:05 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.